Chronic Restraint Stress (CRS) Model Development Service
Are you currently facing challenges in establishing robust and reproducible preclinical models for stress-related disorders? Our chronic restraint stress (CRS) model development service helps you accelerate your research and obtain high-quality, translational data through a scientifically validated and meticulously controlled stress induction protocol. Our service is designed to streamline your project and deliver reliable insights into the complex pathologies of chronic stress.
The CRS model development service provides a scientifically grounded platform for investigating the complex biological and behavioral effects of chronic stress. Rooted in extensive preclinical research, this model is a vital tool for understanding the pathology of stress-related disorders and evaluating the efficacy of potential therapeutic compounds. Our service delivers a meticulously controlled and validated model that serves as a reliable bridge between preclinical findings and clinical applications.
How Our CRS Model Development Service Can Assist Your Project
Our service provides a turnkey solution that delivers a fully validated CRS animal model, saving you valuable time and resources while ensuring the highest level of scientific rigor. We meticulously manage the entire process, from model induction to comprehensive endpoint analysis, allowing you to focus on your research questions.
Discover How We Can Help - Request a Consultation.
Workflow
| Required Starting Materials | To initiate a project, we require a clear statement of your research objectives, a proposed timeline for key milestones, and a list of specific assays or endpoints you wish to measure. This allows us to tailor the model and experimental design to your precise needs. |
| Final Deliverables | You will receive a comprehensive project report, raw and processed data files (including images and molecular readouts), and a scientific summary of the model's characterization. |
| Estimated Timeframe | The typical timeframe for this service ranges from 6 to 12 weeks, depending on the complexity of the desired endpoints and the duration of the stress protocol. |
Why Choose Us?
Choosing Creative Biolabs means partnering with a team that offers over two decades of specialized expertise in preclinical model development. Our unique advantages lie in our commitment to reproducibility, the translational relevance of our models, and our ability to customize every aspect of the service to your research needs.
Experience the Advantage - Get a Quote Today.
Customer Reviews
- We were able to use the CRS model to study its impact on endocrine function, which was a unique application for us. The high-quality hormone assay data we received was invaluable for our study on stress-induced reproductive dysfunction. - K. B***is, Senior Biologist
- The detailed final report from CBL, including the raw data and analysis, was incredibly thorough. It saved my team countless hours of data processing and gave us the confidence to move forward with our findings. The level of detail and scientific rigor was truly impressive. - D. P***son, Principal Investigator
Chronic Restraint Stress (CRS) Model
The CRS model is a well-established paradigm for inducing a state of chronic, unpredictable stress in laboratory animals. The effects are multifaceted, impacting both the central nervous and endocrine systems.
| Description | |
| Neuropsychiatric Applications | The model has been meticulously validated using a multi-modal approach. It consistently induces key neurobiological changes, including functional hypoconnectivity in brain networks involved in emotion and interoception, as measured by resting-state functional magnetic resonance imaging (rs-fMRI). It also leads to a decrease in critical neurometabolites such as glutamate (Glu) and glutamine (Gln) in the sensorimotor cortex, confirmed by proton magnetic resonance spectroscopy (H-MRS). Furthermore, the model reliably causes a reduction in hippocampal volume, a hallmark of chronic stress and depression. |
| Beyond Neurology | The utility of the CRS model extends to other areas of biology. Our precise stress induction protocol leads to a significant elevation of stress hormones like corticosterone and CRH. These hormonal shifts have been shown to impact the reproductive system, causing the excessive activation of primordial follicles in the ovaries and the deregulation of the estrous cycle. We can leverage these effects to investigate the long-term impacts of stress on fertility and overall reproductive health. |
What We Can Offer
Our service provides a comprehensive and flexible solution tailored to your research, ensuring the delivery of a scientifically sound and ready-to-use model.
- Customizable end-to-end service, from initial consultation to final data delivery.
- Scientifically validated CRS model with proven reproducibility and consistency.
- Access to a full suite of analytical techniques for comprehensive characterization.
- Expert guidance throughout the entire process, ensuring your project meets the highest standards of scientific rigor.
- Full documentation and a comprehensive final report to streamline your data analysis and publication efforts.
- Reliable process for producing a consistent CRS model, facilitating robust data generation for your project.
Related Services
To further support your research, CBL offers a suite of complementary services that can be seamlessly integrated with our CRS model development service.
- Target Identification & Validation
- Compound Screening & Profiling
- Pharmacokinetic/Pharmacodynamic (PK/PD) Studies
- Neuroinflammation Research Models
FAQs
Q Is the CRS model suitable for studying a specific disorder like PTSD or depression?
Q Can you customize the CRS protocol to our specific research needs?
We are ready to provide detailed information, answer your questions, and discuss your specific project needs.
Contact Our Team for More Information and to Discuss Your Project.
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
